Apr 21
What’s New
September 24, 2024
Prostate Cancer Awareness: the impact of early detection and expert care
more ›
September 18, 2024
Gratitude to Giving: Celebrating remission by supporting pediatric cancer research
more ›
September 10, 2024
Striking Out Cancer with the Red Sox Foundation and New England Service Scholars
more ›
Research and Patient Care
September 15, 2024
A landmark trial co-led by Dana-Farber showed that about half of patients with metastatic melanoma treated with a combination immunotherapy survive cancer-free for 10 years or more.
more ›
August 21, 2024
The FDA approved belzutifan for adult patients with advanced renal cell carcinoma following a Dana-Farber-led clinical trial.
more ›
